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Abstract
Background and aims: Busy clinical settings often restrict the possibility to focus on concepts that
determine health in a positive way, commonly assessed by using patient-reported outcomes (PROs).
We aimed to explore which determinants of health (DHs) are important to people with Crohn's disease
(CD), to understand possible gender differences and to analyze whether these DHs are covered by
PROs used in CD.
Methods: Two systematic literature reviews were done to identify relevant DHs and clinically
relevant PROs. We conducted a qualitative narrative biographical study and mapped the
patients' experiences to concepts that determine health in a positive way. Experiences, DHs andof health; DHs, determinants of health; HP, health promotion.
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46 M. Dür et al.the items of the PROs were compared by the WHO International Classification of Functioning,
Disability and Health (ICF) as a common framework.
Results: 15 people with CD with a median age of 46 years (IQR 34–60) and median disease
duration of 15 years (IQR 8–30) participated. Self-efficacy, social support, job satisfaction and
occupational balance were mentioned most frequently. While participation appeared to have
greater meaning to men, appreciation and resilience seemed to be more important for women.
Of 18 PROs the Perceived Stress Questionnaire (PSQ), the Inflammatory Bowel disease —
Self-efficacy scale (IBD-SES), the Life Orientation Test — Revised (LOT-R) and the Patient
Activation Measure 13 (PAM-13) cover most DHs.
Conclusions: This is the first study elaborating the coverage of patient's perspective by
commonly used PROs in CD. The findings could support health professionals to focus on DHs in
people with CD in clinical practice and research.
© 2013 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.his subject?
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Crohn's disease (CD) is an inflammatory bowel disease (IBD)
with a broad spectrum of clinical manifestations. CD may
affect the entire gastrointestinal tract with discontinuous
lesions involving all bowel layers. An irregular disease course
with active and inactive periods is characteristic.1 CD may
profoundly change or influence the patient's life situation,
quality of life, health and wellbeing.2
Several determinants of health (DHs), such as social
support and optimism are recognized to have an impact on
the course and outcome of chronic inflammatory diseases.3,4
DHs include the social, economic and physical environment, aswell as the person's individual characteristics and behaviors,
and can affect health either in a positive or in a negative way.5
There is a slight female predominance among patients with
CD.1 In CD, nervous, endocrine and immune functions, the
course of the disease, experiences and the consequences in the
management of CD show differences between women and
men.6–8
Health outcome research seeks to understand the end
results of health care in a particular disease, an individual, or a
group of patients. A scientific basis for understanding and
studying health including patients' perspectives is needed.9–11
Patient reported outcomes (PROs) assess patients' perceptions
within various dimensions of health, which still may deviate
47Important health determinants and their coverage by PROsfrom patients' priorities for improvement of health.12 Other
issues of health and well-being, such as DHs, beyond clinical or
pathophysiologic aspects of a disease, may however be
important to the people.10
Qualitative research allows gaining deeper understanding
of the life world of other people. In the development and
validation of PROs, this perspective is essential, otherwise
PROs may lack issues important to patients that health
professionals have not thought about. Qualitative research is
needed to identify the concerns of people living with CD.9
Qualitative research differs fundamentally from quantita-
tive research in that it generates knowledge about the
individuals' experiences, attitudes, views and preferences,
taking an in-depth approach to the issue it studies in order to
understand it more thoroughly.13
The importance of DHs may change over time and
disease course. Thus DHs need to be explored within a
long-term perspective over the course of life. This allows
understanding the current situation and experiences of an
individual taking into account the whole life story. The
narrative biographical method is a research method that
combines the past experiences with the present life
context.8,14
Patients' perspectives have not been included into the
development of CD-specific PROs so far. An examination
whether they cover patients' perspectives based on qualitative
data was not done yet.15,16 Furthermore, potential gender
differences in the experiences of living with CD have not been
reported.
The research questions of this paper were, therefore:
i) Which DHs are meaningful for people with CD and are there
gender differences? ii) Are these DHs covered by PROs used in
people with CD?Exploring DHs 
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2.1. Design
We conducted: (i) a first literature review to identify concepts
that determine health in a positive way in patients with CD, (ii)
a second literature review to determine PROs used in CD and
(iii) a qualitative narrative biographic study to explore the
experiences of people with CD in daily life over the course of
their life time. DHs, the items of the PROs and experiences of
people with CD were compared by using the WHO International
Classification of Functioning, Disability and Health (ICF)11 as a
common framework. Fig. 1 depicts a scheme of the method.
2.2. Literature review to select specific
determinants of health
The first systematic literature review was done to identify
concepts that determine health in a positive way. The
inclusion criteria for a concept were: 1) mentioned in more
than five publications, 2) valid or single and generally agreed
definition available (such as from WHO), 3) evidence of its
positive impact on health and 4) a relationship to functioning
in daily life. In autumn, 2011 the databases PubMed, Web of
Science, PsycINFO, and WHO IRIS were searched for the
following keywords: DH, health promotion, and those DHs
which were identified in a preliminary search to find
appropriate search terms (such as social support,
self-efficacy etc.).
Based on the selected list of DHs, we explored whether
each DH was mentioned in the life stories of people with CD.
This step was done by two researchers (MD, MS and/or TS)terviews
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48 M. Dür et al.independently. In case of disagreement, each case was
discussed in the research panel of three people who made a
final informed decision. Frequencies of the concepts covered
in the life stories were calculated using SPSS.172.3. Qualitative narrative analysis
2.3.1. Participants
People with diagnoses of CD18 were selected from our
gastroenterology outpatient clinic; ‘Maximum variation
sampling’19 was followed considering gender, age, level of
education, professional status and disease duration.
Criteria for participation were (i) no history of psychiatric
and/or neuro-motor disease unless medically well con-
trolled, and (ii) German as their first language.2.3.2. Data collection
Participants were interviewed by one of two trained
people (MS, MD), skilled and experienced in interviewing
techniques. Participants received one general interview
question asking them to tell their life stories and followed
by specific questions regarding the told life events. In-
terviews lasted between one and 2.5 h. Participants were
interviewed twice in order to give the interviewee and the
interviewer the opportunity to reflect on what was said in
the first interview session. All interviews were tape
recorded and transcribed verbatim.
The transcripts were analyzed using the biographical
narrative interpretative method which combines the explora-
tion of the experiences of an individual from the perspective
of the told narrative life-story and its relation to the
biographic data.20 It is a conceptual analysis of the impact
of CD on people's interpretation of their life's experience
and biography. The steps of the qualitative method are
depicted in the mid column in Fig. 1. Rigor and accuracy of
this analysis were established by writing a reflective
research diary by the first author and by using a research
panel of at least three people to generate hypotheses
regarding the meaning of what was told by the participants.2.4. Literature review to identify PROs
The second systematic literature review was performed to
identify PROs in CD. The following inclusion criteria for a
PRO were applied: 1) assessing functioning, health and
wellbeing, and/or one or more DH, 2) specifically devel-
oped for or validated in patients with CD, 3) published in a
peer-reviewed journal and 4) published in English. In spring
2012, PubMed, CINAHL, PsycINFO were searched using the
following keywords: CD, assessment, instrument, invento-
ry, outcome measure, PRO, questionnaire, survey, scale
and the specific DH (see Table 1). Descriptive, evaluative,
and psychometric studies, reviews and articles that report
the use of PROs in CD were selected. Case reports,
economic evaluations and primary prevention studies
targeted to so called healthy people (without a chronic
disease) to prevent the development of IBD, and tools
which considered disease activity or course of disease only
were excluded.2.5. ICF-based analysis
DHs and the extracted items of the PROswere compared based
on the ICF. In the first step, the DHs as well as the items of the
PROs were linked to the ICF categories by two researchers
independently (MD, MC). The linking exercise followed a
standard procedure and is similar to “translating” a concept or
an item into “a common ICF language”.21 An example is given
in Fig. 2. Due to the complexity of some of the selected DHs
theywere linked to asmany ICF codes as necessary to describe
them, such as self-efficacy given in Table 5, which is linked to
four ICF codes. Additionally, available literature providing ICF
codes linked to specific PROs was used.15,16,22,23
2.6. Ethical considerations
Participants were informed about the study procedures and
the ethical considerations.Written and oral informed consents
were obtained. Confidentiality of the participants and the
data was guaranteed. Therefore, the names given in relation
to the quotes were changed. The study was approved by the
ethic committee of the Medical University of Vienna, Austria.
3. Results
Based on the first literature search 13 DHs were selected,
depicted and defined in Table 1.
In the qualitative study 15 people (eight women and
seven men) with CD and a median disease duration of
15 months (IQR 8–30) participated. The median age was
46 years (IQR 34–60) and the median disease activity score
assessed by the Harvey Bradshaw Index,24 was 7 (IQR 3–8),
indicating a mild disease activity. Nine people were
employed, five participants were retired, and one person
was studying at the first interview. Demographical data of
the participants per sex are depicted in Table 2.
The frequency of the DHs as well as gender differences
found in the life stories are presented in a ranked order in
Table 3. Both self-efficacy and social support were
mentioned by 14 (93%), job satisfaction and occupational
balance were both reported by 13 people (87%). These most
frequently mentioned DHs applied to both sexes. While
participation was of greater meaning for men compared
with women (86 vs. 38%), resilience appeared to have more
importance for women than men (63 vs. 29%).
For example, Lukas described job satisfaction as:
“It was fun, it was not, regarding satisfaction it was not gratifying
completely, but the division and my colleagues were ok.Work was
interesting always, salary was adequate” (Lines149–152).
We identified occupational balance when Lukas talked
about his meaningful activities:
“I do a lot as handyman at home, with joy, not with a must. I
start socializing, go to events and do gymnastics.What I am able
to do, I do” (Lines 129–131).
Lukas experienced a disease course which is typical for CD
characterized by several flares, with occasional mild improve-
ments of disease activity followed by recurrence of more
Table 1 Definitions of the selected determinants of health.
Determinants of health Definition
Appreciation The construct of appreciation, the perception of popularity/acceptance by one's peers is typically
used in the context of children and adolescent; it bases on feelings of social inclusion and of
connectedness.45
Coping Coping means constantly changing cognitive and behavioral efforts to manage specific external
and/or internal demands that are experienced as stressful or exceeding the resources of the person.46
Vocational gratification This term bases on the equity theory and the notion of contractual reciprocity.
Vocational gratification can be defined as the experience of pleasing or satisfaction with the reward
for the given effort in the context of employment.47
Secondary gain from
illness
The term gain means the advantages of an illness experienced by the patient and that hinder
recovery are generally termed “gain”. “Secondary gain from illness” defines a preconscious holding
on to the illness because of supposed or real advantages.48
Job satisfaction It is a pleasurable or positive emotional state resulting from the appraisal of one's job or job
experience.49
Occupational balance It is understood as a balance of social demands. Then an individual is experiencing (a) challenging
and relaxing activities, (b) activities meaningful for the individual and activities meaningful in a
sociocultural context and (c) activities intended to care for oneself and activities intended to care
for others.50
Societal participation Societal participation is the person's involvement in a life situation and in relations to other people
(participation in society).11
Optimism Optimism in the context of the current study means reflecting about one's life in a positive way
despite a chronic disease respectively to have optimistic perspectives.
It includes experiencing a chronic disease as a source for new challenges and the positive aspects –
“benefits” – to having impairment.51,52
Resilience In psychology resilience refers to the idea of an individual's tendency to deal with stress and adversity.
This may result in the individual “bouncing back” to a previous state of normal functioning,
or using the experience of exposure to adversity to produce a “steeling effect” and function better
than expected.44
Self-efficacy It is our belief in our ability to succeed in certain situations. It is the individual's confidence in his
or her ability to do a specific task or achieve certain outcomes.53
Sense of coherence Sense of coherence means perceiving the world coherent. It consists of three components:
comprehensibility, manageability and meaningfulness. Comprehensibility is a belief that things
happen in an orderly and predictable fashion and a sense that you can understand events in your
life and reasonably predict what will happen in the future. Manageability is one's belief that you
have the skills or ability, the support, the help, or the resources necessary to take care of things, and
that things are manageable and within your control. Meaningfulness covers a belief that things in life
are interesting and a source of satisfaction, that things are really worth it.54
Social support Social support refers to social connections, social network support and the frequency of social
contact.55
Work–life balance It is defined as the distribution of people's time between paid work and non-work activities — time
with family, commuting, leisure and personal care.56
49Important health determinants and their coverage by PROsactive disease.18 In 2008, he experienced significant recru-
descence, additionally he fell into a deep depression. A stay in
a psychosomatic inpatient clinic for twoweeks changed his life
dramatically. He experienced self-efficacy regarding his
health and wellbeing, as well as his disease course:
“I had individual and group therapy. I've talked about my
feelings, and about my pain and it [the pain] got better and
better, until I had no” (Lines 101–105). “I felt better and better,
no fatigue, regained strength, and started with sports again, I
had become active again” (Lines 113–115). “In the past I have
always been dissatisfied, because I could not make my own
hours,work, or because I took on too much and I couldn't manage
it, then I was dissatisfied. Today, I do not plan in advance to do
something, I just do it spontaneously” (Lines 160–162).After some years of living with the disease Lukas felt
better than expected. We identified resilience in various
sequences such as:
“I was told that it will not get better; I will not recover; I
thought there goes my whole life (Lines 167–170). Now, I am
pleased with it. I got better and better, and currently I feel
better than in all the years before everything had started
[disease]. I am healthy; I am absolutely in best constitution”
(Lines 178–185).
Another example is given with Frank for whom social
participation means to care for his health. His attendance at a
Buddhist center was meaningful first and foremost to meet
people, and participate and to be a part of a community:
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PAM-13: Item 12
I am confident I can 
figure out solutions when 
new problems arise with 
my health
b1265
b1643
b1646
d570
Optimism
Cognitive flexibility
Problem-solving
Looking after one’s 
health
Coping
Self-efficacy
Reflecting about one’s life 
in an optimistic 
way/Optimism
Sense of Coherence
PAM-13: Item 13
I am confident that I can 
maintain lifestyle 
changes, like eating right 
and exercising, even 
during times of stress
d2401
d5701
b1265
Handling stress 
Managing dieting and 
fitness
Optimism
Coping
Self-efficacy
Reflecting about one’s life 
in an optimistic way / 
Optimism
IBD-SES: Item 28
Engage in stress 
management program 
d2401
d5702
Handling stress 
Maintaining one’s health
Coping
Self-efficacy
ESSI: Item 4
Is there someone 
available to help with 
daily chores?
d230
e399
Carrying out daily routine 
Support and 
relationships, unspecified
Social Support
Figure 2 Examples for linking PROs' items to ICF codes and/or DHs. Abbreviations: ESSI=ENRICHD Social Support Instrument,
IBD-SES= Inflammatory Bowel Disease — Self-Efficacy Scale, ICF= International Classification of Functioning, Disability and Health,
PAM-13=Patient Activation Measure 13 item version.
50 M. Dür et al.“We meet there at the weekend, the activities can be very
exhausting, what, on the other hand, is real fun, I love to be
there. I go there with a bored face, and leave happy. Thereable 2 Demographic data of the participants per sex.
ge median (IQR) range Disease duration median
(IQR) range
Highest level of
omen (8)
3 9 L5
8 22 L2
4 22 L2
7 6 L3
9 29 L3
3 1 L3
5 18 L3
5 15 L2
0.5 (28.75–58)
25–63
16.5 (9–22)
b1–30
en (7)
3 8 L3
7 4 L3
5 9 L5
6 30 L5
2 2 L3
0 37 L3
0 31 L3
0 (37–62)
25–63
9 (4–31)
2–37
2=secondary education first stage/second step of basic education, L3=s
5=first stage of tertiary education, not leading directly to an advanced rare many people to exchange, I am glad that I have found
that, it has become to a very important part of my life”
(Lines 33–39).education Professional status Harvey Bradshaw Index24
(disease activity)
Employed 6 (mild)
Employed 3 (remission)
Employed 3 (remission)
Employed 2 (remission)
Retired 7 (mild)
Retired 12 (moderate)
Retired 7 (mild)
Student 7 (mild)
Retired 15 (moderate)
Employed 6 (mild)
Employed 4 (remission)
Employed 11 (moderate)
Retired 1 (remission)
Employed 23 (severe)
Employed 6 (mild)
econdary education second stage/upper secondary education,
esearch qualification,57 IQR=interquartile range.
Table 3 Frequency of determinants of health in the life
stories in a ranked order.
DHs Rank n f m
Self-efficacy 1 14 7 7
Social support 1 14 8 6
Job satisfaction 2 13 7 6
Occupational balance 2 13 7 6
Participation (social) 3 9 3 6
Coping 4 8 4 4
Appreciation 4 8 5 3
Resilience 5 7 5 2
Reflecting in a positive way/optimism 5 7 4 3
Vocational gratification 5 7 3 4
Sense of coherence 6 6 3 3
Secondary gain from illness 7 3 1 2
Work–life balance 8 2 1 1
Total n 15 8 7
Abbr.: DHs: Determinants of health, f: female, m: male; n:
number.
51Important health determinants and their coverage by PROsSandra suffered from stomach-ache since her childhood,
lost 16 kg of weight and was diagnosed with CD when she was
16 years old. Social support means a lot for Sandra and her
disease management:
“I could always lean on all of them [family], if there was
something and I was unwell. Someone was there for my son,
and my husband anyway, and the whole family actually;
whenever I said I feel badly they were there, and they still
are” (Lines 104–108).
The linked ICF codes of the DHs are depicted in Table 5. An
example of the linking process is given in Fig. 2. Five DHs,
namely vocational gratification, job satisfaction, occupational
balance, sense of coherence and work–life balance are not
covered by the ICF.
In the second literature review 18 relevant PROs were
identified and examined; they are listed and briefly described
in Table 4.
The coverage of ICF codes for the Beck Depression Inventory
(BDI),25 the EuroQuol Health Questionnaire (EQ-5D),26 the
Short Form-36 Health Survey (SF-36),27 the IBD Questionnaire
(IBDQ-32)28 and for the Short IBD Questionnaire (SIBDQ)29 were
provided.16,22,30,31 The examination of these PROs' coverage
rests upon the quoted articles. The thirteen remaining PROs
contained 324 items which were linked to 266 ICF codes; the
mapping of the codes personal factor as well as not covered
was not considered. None of the PROs covers all DHs,
respectively linked ICF codes. The most frequent covered ICF
code was b126 temperament and personality functions (10),
followed by b1263 psychic stability (8). Social support is
covered by five, self-efficacy by two PROs, reflection in an
optimistic way, is covered most often. We recommend the use
of the following four PROs due to the amount of covered DHs:
the Perceived Stress Questionnaire (PSQ),32 the Inflammatory
Bowel Disease — Self efficacy scale (IBD-SES),33 the Patient
Activation Measure 13 (PAM-13),30and the Life Orientation
Test — Revised (LOT-R).34 Coping, reflecting in an optimisticway and self-efficacy could be assessed routinely with the PSQ,
the IBD-SES and the PAM-13. Resilience is covered by the
LOT-R, the PAM-13 and the PSQ. Social support is covered by
the IBD-SES, the PSQ and the LOT-R. Moreover the LOT-R is the
only PRO assessing social participation. The PSQ addresses
most DHs (5). The coverage of the DHs by the PROs is shown in
Table 5.4. Discussion
In this study we identified and critically appraised DHs
which complement commonly used outcomes such as
disease activity, from the perspective of people with CD.
The examination of the 18 selected PROs applied in CD,
showed that they cover few DHs which are meaningful for
people with CD also.
It has been argued that outcomes in research and clinical
practice should capture the perspective of patients with
CD.9,10 Our study explores the perspectives of patients with
CD focusing on problems, but also on resources. PROs in CD
have already been examined whether they cover several ICF
codes.16,35,36 Their coverage of patient's perspective has not
been explored as it was done in other chronic autoimmune
diseases, so far.37,38 To our knowledge, this is the first study
examining PROs regarding patients' perspectives of people
with CD based on qualitative research and regarding the
coverage of DHs.
The latest NICE-guideline on CD focus on management
and research in people with CD.9 However it does not give
recommendations on which of the existing PROs should be
used. Thus our paper suggests how to address other DHs
beyond disease activity in CD. The use of the recommended
PROs can support clinicians and health professionals to
address other meaningful DHs.
Social support and self-efficacy should be considered to
a greater extent in clinical practice and research, because
in our study they were the most important DHs for the
patients with CD. This is in accordance with literature as
social support and self-efficacy were found to determine
disease course and health.33,39 In a related study in
rheumatoid arthritis social support was important to 67%
and self-efficacy 47%.40 Moreover, due to little evidence,
other meaningful concepts such as job satisfaction and
occupational balance require further research.41–43
The identified gender differences need further investiga-
tion and should be treated with caution due to small sample
size. Gender differences of DHs in CD have not been reported
elsewhere. In this study, women's disease duration was longer,
even though they were younger than the men. Thus, women
could have had more time to develop resilience. Men could
have found it harder to maintain social participation, as found
in other studies.8
The utilization of the PSQ, the IBD-SES, the LOT-R and
the PAM-13 in clinical routine would be meaningful for
patients with CD. The most suitable PRO appears to be the
PSQ covering the most and meaningful DHs. The IBD-SES,
the LOT-R or PSQ could be used to take account the meaning
of social support (93%) and its substantial effect on
health.3,44 Self-efficacy that is also important to people
with CD could be addressed by the use of the IBD-SES,
PAM-13 and the PSQ.
Table 4 Characteristics of the identified patient-reported outcomes.
Abbr. Patient-reported outcomes Content Items Response options Time frame
ADAPT Assessment of the Demand for Additional
Psychological Treatment58
Need for psychological treatment 12 Visual analog scales Present
BDI-II Beck Depression Inventory-II25 Depression 21 4 statements: increasing severity Past, present, future
CPWDQ Crohn's disease Perceived Work Disability
Questionnaire59
Work capacity 14 4 statements: increasing frequency
(1=never, 4 all of the time)
Last year
DS-14 Type-D Scale60 Negative affectivity & social
inhibition
14 Verifying statements (0=false to 4=true) Present
EQ-5D EuroQuoL Health questionnaire26 Health status 5 Statement (no, some, extreme
problems) & visual analog scale
Present
ESSI ENRICHD Social Support Instrument61 Extent of social Support 7 Question 1–6 (None, a little, some, most
or all of the time), Question 7 (yes/no)
Present
FIQL Fecal Inconsistency Quality of life Scale62 Health related Quality of Life 29 Different Likert scales Present
HADS Hospital Anxiety and Depression Scale63 Anxiety, depression 14 Frequency: 4-point Likert scale (0=not
at all, 4=definitely)
Present
IBDQ-32 Inflammatory Bowel Disease Questionnaire28 Health related quality of life 32 7 point Likert scale (1=significant
impairment, 7=no impairment)
2 weeks
IBD-SES Inflammatory Bowel Disease Self-efficacy
Scale33
Self-efficacy 29 10 point Likert scale (1=not sure at all,
10 totally sure)
Present
LOT-R Life Orientation Test-Revised34 Optimism 8 5 point Likert scale (0=strongly disagree,
4 strongly agree)
Present
PAM-13 Patient-Activation Measure Short Form64 Health management skills, knowledge,
confidence, motivation
13 5 point Likert scale (0=strongly disagree,
4 strongly agree; 0=poor, 4=excellent)
Present
PSQ
-V, -G
Perceived Stress Questionnaire32 recent form
(PSQ-V)/general form (PSQ-G) covering the
Perceived stress 30 4-point scale on frequency (1=almost
never, 4=usually)
Past month/past 2 years
PSQ-R Perceived Stress Questionnaire Reconsidered65 Perceived stress 20 4-point scale on frequency (1=almost never,
4=usually)
Present
RFIPC Rating Form of Inflammatory Bowel Disease
Patient Concerns66
Worries, concerns regarding IBD 25 Visual analog scale (0=Not at all, 100=A
great deal)
Present
SF-36 Short Form 36 Health survey27 Health related quality of life 36 Different response scales 4 weeks
SIBDQ Short Inflammatory Bowel Disease
Questionnaire29
Quality of life 10 7-point Likert scale on frequency (1=all
of the time, 7=none of the time)
2 weeks
STAI State-Trait Anxiety Inventory67 Anxiety about an event, and trait
anxiety
40 Intensity 4-point Likert scale (1=not at all,
4 very)
Present
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Table 5 Coverage of the determinants of health by patient-reported outcome instruments.
Determinants of health
ICF
Codes titles A
D
A
PT
BD
II
I
CP
W
D
Q
D
S
14
EQ
5D
ES
SI
FI
Q
L
H
A
D
S
IB
D
Q
32
IB
D
SE
S
LO
T
R
PA
M
13
PS
Q
PS
Q
R
RF
IP
C
SF
36
SI
BD
Q
ST
A
I
Appreciation
e4 Attitudes + + +
Coping + + + + +
d240 Handling stress and other psychological
demands
+ + + + +
Gratification (vocational)
nc Not covered by the ICF
Gain from illness (secondary)
pf Personal factor
Job satisfaction
nc Not covered by the ICF
Occupational balance 
nc Not covered by the ICF
Participation (social) + + + +
d9 Community, social and civic life + + + + + +
Reflecting about one’s life in an optimistic way
b126 Temperament and personality functions + + + + + + + + + + +
b1265 Optimism + + + + + +
pf Personal factor
Resilience + + +
b1263 Psychic stability + + + + + + + + +
pf Personal factor
Self‐efficacy + +
b1641 Organization and planning +
d177 Making decisions +
d570 Looking after one’s health + +
pf Personal factor
Sense of coherence
nc Not covered by the ICF
Social support + + + +
e3 Support and relationships + + + + +
Work‐life balance
nc Not covered by the ICF  
ICF: International Classification of Functioning, Disability and Health; ADAPT: Assessment of the Demand for Additional Psycho-
logical Treatment; BDI: Beck Depression Inventory; CPWDQ: Crohn’s disease Perceived Work Disability Questionnaire; DS-14: 
Type-D Scale 14; EQ-5D: EQ-5D Health Questionnaire; ESSI: ENRICHD Social Support Scale; HADS: Hospital Anxiety and Depres-
sion Scale; IBDQ 32: Inflammatory Bowel Disease Questionnaire 32; IBD SES: Inflammatory Bowel Disease –Self-Efficacy Scale; 
LOT-R: Life Orientation Test Revised; PAM-13: Patient Activation Measure Short Form; PSQ: Perceived Stress Questionnaire; 
PSQ-R: Perceived Stress Questionnaire Reconsidered; RFIPC: Rating Form of Inflammatory Bowel Disease Patient Concerns; SF36:
Short Form 36; SIBDQ: Short Inflammatory Bowel Disease Questionnaire; STAI: State-Trait Anxiety Inventory;
53Important health determinants and their coverage by PROs4.1. Limitations
Qualitative research uses small sample sizes in order to
generate meaning and to allow in-depth analyses of each
case. However for generalizability of the findings quanti-
fication on larger samples in quantitative studies may beneeded. Furthermore the use of other keywords and data
bases could have led to different findings. A limitation
might be that all participants were of one hospital.
When using the ICF as framework clarification is needed
on how to deal with DHs which were a) partially covered,
b) linked to personal factor, or c) not covered by the ICF. In
54 M. Dür et al.this study we mapped these items according to the
definitions of the DHs. Issues that are not covered by the
ICF and are missing in the ICF should be included in the
update process of the ICF which has already been initiated
by the WHO. Furthermore there is a need for guidance of
the process of mapping concepts which cannot be covered
by the ICF, according to its purpose and definition.21
4.2. Implications of findings
This is the first study elaborating the coverage of patient's
perspective by commonly used PROs in CD. Social support,
self-efficacy and gender differences should get more attention
in clinical practice and research. The use of the PSQ, the
IBD-SES, the LOT-R or the PAM-13 is recommended.
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